Empowering Venture Capital Associates
Enrique Lin Shiao is Head of Search & Evaluation at the Cystic Fibrosis Foundation investing in new technologies towards novel treatments and cures for cystic fibrosis. Before joining CFF, he worked in asset acquisitions at BridgeBio Pharma, where he focused on sourcing and investing in novel therapies for rare diseases. Prior to that, Enrique trained as a biomedical scientist completing his PhD in Genetics at the University of Pennsylvania and a postdoc in Gene Editing in the laboratory of Nobel Laureate Jennifer Doudna at UC Berkeley.
Join hosts Mike Hostetler and Jen Fang as they talk with Enrique Lin Shiao, a venture investor exploring the intersection of science, business, and philanthropy. Enrique shares his path from earning a PhD at the University of Pennsylvania to working with the Cystic Fibrosis Foundation (CFF) where he helps drive investment in breakthrough genetic therapies. He also discusses his podcast, Caminos en Ciencia, which highlights diverse career paths in science across Latin America. This engaging dialogue explores the impact of venture philanthropy in biotech, the challenges of developing treatments for cystic fibrosis, and how organizations like CFF are shaping the future of genetic medicine. Listen in for insights on funding innovation, advancing life-changing research, and the role of biotech investment in tackling rare diseases.
Mike is a partner in the San Francisco (SoMa) and San Diego offices of Wilson Sonsini Goodrich & Rosati. He has provided strategic intellectual property counseling to hundreds growth enterprises in the pharmaceutical and biotechnology industries, both venture-backed and public companies. His expertise includes patent strategy, prosecution, and diligence (both buy and sell side) for venture financings, public offerings, mergers and acquisitions.
Jennifer is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative startups grow into successful enterprises by providing counsel to the founders, management teams and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is a member of the National Venture Capital Association (NVCA) General Counsel Advisory Board and is a frequent speaker.